In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
A key part of the growth strategy for the Ted Rogers Centre for Heart Research is in establishing a team of chairs whose expertise and vision will help drive each aspect of the overall vision. In some cases, a chair position has transformed into two “innovator” roles, as well as a program, in order to best address emerging areas of interest and new opportunities.
Dr. Michael McDonald appointed June 2021
Goal: To support and grow educational opportunities for our community of basic science and clinical trainees while building out the Heart Function Fellowship program, attracting high-quality fellows from around the world, and integrating educational strategies in heart failure at all academic levels.
Daniel Franklin appointed May 2021
This chair will support our Translational Biology and Engineering Program and, as a result, all collaborators inside and outside the Ted Rogers Centre.
Launched in November 2019
This program reflects the Centre’s escalating focus on data science, and is set up to enable greater ‘Big Data’ research currently underway at our Comprehensive Program in Heart Function. It is designed to provide analytical and methodological expertise, spanning traditional biostatistics to advanced machine learning, health system and technology assessment, and quality improvement to the breadth of research underway at the Centre.
Dr. Rajiv Chaturvedi appointed December 2019
This endowed scientist position provides additional support to our Cardiac Precision Medicine team. Dr. Chaturvedi’s work has been delayed due to COVID restrictions. He has obtained gene expression data from left ventricular myocardium from a fetal lamb model of hypoplastic left heart syndrome, and is exploring other alternatives for this model. New fetal studies are in planning stages.
Dr. Slava Epelman appointed April 2018
Goal: Catalyze existing research strengths and bring new expertise to solve unaddressed immunology-related problems in heart failure and regenerative cardiac therapy.
Dr. Douglas Lee appointed June 2016
Goal: Study how health policy, health system and patient factors affect the natural history and outcomes of individuals with heart failure. The Chair will exploit the unique cardiovascular database, disease modelling and systems biology capacity of the Ted Rogers Centre to inform their studies, integrate novel biological markers and available genetic markers into their analyses and formulate health policy advice.
This chair will support our Translational Biology and Engineering Program and, as a result, all collaborators inside and outside the Ted Rogers Centre.
This chair will help drive the mission of our Cardiac Genome Clinic to not only discover novel genomic markers of heart failure, but translate them into clinic impact.
This endowed scientist position provides additional support to our Cardiac Precision Medicine team, and will focus on new avenues of genetic pursuits.
